JERUSALEM, June 10, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), ("Scinai" or the "Company"), a biopharmaceutical company combining innovative therapeutic development with a revenue-generating CDMO subsidiary, today reported financial results for the three months...
Hence then, the article about scinai reports first quarter 2026 financial results and provides corporate update highlighting expansion of cdmo platform and advancement of strategic growth initiatives was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives )
Also on site :
- ’90s Rock Band Extends 2026 Tour With Special Guests
- 1965 Folk Rock Classic, Ranked Among 'Greatest Protest Songs of All Time,' Became a Cross-Generational Anthem
- Charities in England and Wales ‘donate millions to illegal Israeli settlements’